Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

This month the FDA has approved Journavx, a medication that mimics proteins that can help block pain signals from reaching ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

Shares of Vertex Pharmaceuticals gained about 6% Friday morning, after the pharmaceutical company won U.S. approval for the ...

Stop me if you’ve heard this one before: A miracle new painkiller promises to save us all from the scourge of addiction while effectively treating acute and perhaps even chronic pain.